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Background: Growing evidence suggests that abdominal obesity is a more important risk factor for the prognosis of
cardiovascular and metabolic diseases than BMI. Somatic-affective symptoms of depression have also been linked to
cardiovascular risk. The relationship between obesity and depression, however, has remained contradictory. Our aim
was therefore to relate body mass index (BMI) and different measures for abdominal obesity (waist circumference, WC,
waist-to-hip ratio, WHR, waist-to-height ratio, WHtR) to somatic vs. cognitive-affective symptoms of depression.
Methods: In a cross-sectional population based study, data on the first N = 5000 participants enrolled in the Gutenberg
Health Study (GHS) are reported. To analyze the relationship between depression and obesity, we computed linear
regression models with the anthropometric measure (BMI, WC, WHR, WHtR) as the dependent variable and life style
factors, cardiovascular risk factors and psychotropic medications as potential confounders of obesity/depression.
Results: We found that only the somatic, but not the cognitive-affective symptoms of depression are consistently
positively associated with anthropometric measures of obesity.
Conclusions: We could demonstrate that the somatic-affective symptoms of depression rather than the
cognitive-affective symptoms are strongly related to anthropometric measures. This is also true for younger obese
starting at the age of 35 years. Our results are in line with previous studies indicating that visceral adipose tissue
plays a key role in the relationship between obesity, depression and cardiovascular disease.
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Although relations between obesity and somatic condi-
tions are unambiguous [1,2], there is an ongoing debate
about the usefulness of the Body Mass Index (BMI) as a
prognostic factor for cardiovascular and metabolic disease.
While, BMI can be measured easily and reliably (only
weight and height measures are necessary), there are some
concerns about the reliability of the measurement of waist
or hip circumference depending on the precise site at
which they are measured [3]. BMI was a strong predictor
for overall mortality in a sample of 900.000 participants of
57 prospective studies from different countries (92% of the
participants were in Europe, Israel, the USA, or Australia).* Correspondence: joerg.wiltink@unimedizin-mainz.de
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reproduction in any medium, provided the orEach gain of 5 kg/m2 was associated with a 40% increase
of vascular mortality [4].
Growing evidence of comparison studies, however,
suggests that abdominal obesity is a more important risk
factor for cardiovascular and metabolic diseases than
general obesity. A recent prospective study with a total
of 6.355 participants compared BMI, waist circumference
(WC), waist-to-height ratio (WHtR) and waist-to-hip ratio
(WHR); WHtR was the best predictor of cardiovascular
risk and mortality (followed by WC and WHR) [5]. Based
on the finding that the measure of abdominal fat pro-
vided a better assessment of risk of death among people
with lower BMI (in a study with 360.000 participants),
screening of WC and WHR was suggested in addition
to BMI [6].
Visceral adipose tissue seems to play a key role in car-
diovascular diseases (CVD), obesity and depression. As
reviewed by Shelton & Miller, however, the underlyingLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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understood [7] (for an overview). Studies have shown that
visceral fat produces a higher amount of cytokines than
subcutaneous fat [8]. High levels of cytokines such as TNF-
alpha, IL-6 and C reactive protein have been found both in
visceral obesity and in depression [9]; this finding has been
replicated consistently [7]. An unhealthy life style, diabetes,
CVD and inflammation may induce vascular damage in the
brain, which may also lead to depressive symptoms [10].
Another potential mechanism linking obesity and depres-
sion is a dysregulation of the hypothalamic-pituitary-ad-
renal axis e.g. [11].
The relations between obesity and comorbid mental
conditions are still discussed controversially. An increased
prevalence of depression and other mental disorders in
obese was found in several studies e.g. [12-14] and con-
firmed by a meta-analysis including seventeen community
based studies with more than 200.000 participants [15];
the causal link between depression and obesity is sup-
posed to be bidirectional [16]. Others, however, could
not find an increased prevalence for mental disorders in
the obese at all. e.g. [17-19]. However, only few studies
have compared different anthropometric measures, even
though they are quantitative, non-invasive and easy to de-
termine techniques for determining body fat composition.
The abdominal fat distribution (measured by WHR)
appeared to be the key mediator of the relationship be-
tween obesity and depression in a large cross sectional
study with 65.648 adults [20]. A recent report of a large
community sample of older (70 to 79 years old) partici-
pants could demonstrate the increased risk of onset of
depressive symptoms in initially non-depressed obese
men, but not for obese women during a 5 year follow
up. Men with high visceral fat had a more than 2-fold
increased risk of being persistently depressed compared
to those with a normal amount of visceral fat; the associ-
ation with depressive symptoms was more consistently
related to abdominal obesity than to overall obesity [21].
Recent studies have shown that somatic-affective (e.g.
feeling tired or having little energy), but not cognitive-
affective (e.g. feeling down, depressed, or hopeless)
symptoms of depression predicted poor medical out-
comes in patients with cardiovascular disease e.g. [22].
However, this distinction has not been made by the
aforementioned studies [20,21]. In a Dutch study with
1284 participants (50 to 70 years old) a positive correl-
ation was found between all different measures of de-
pressive symptoms (Beck Depression Inventory) and
BMI, although the association between measures of vis-
ceral obesity (WC and WHR) was primarily driven by
the somatic-affective symptom cluster [23].
Contradictory findings regarding the relationships be-
tween obesity and depression may be due to (a) the
different measures of obesity (BMI or abdominal fatdistribution) used, (b) the different measures of depres-
sion, esp. somatic-affective vs. cognitive-affective symp-
toms of depression and (c) potential sex differences (d)
the u-shaped relationship between body weight and de-
pression (e.g. [23-25]).
Therefore, our aim was to compare BMI as a measure
for general obesity with different anthropometric measures
for abdominal obesity (WC, WHR, WHtR) to somatic-
affective and cognitive-affective depressive symptoms in a
cross-sectional population based sample. We expected a
closer relationship to depression in the measures of ab-
dominal obesity compared to BMI and for somatic-
affective vs cognitive-affective symptoms of depression.
Methods
Procedure and study sample
We investigated cross-sectional data of the first N =
5000 participants enrolled in the Gutenberg Health
Study (GHS) from April 2007 to October 2008. The
GHS is a population-based, prospective, observational
single-center cohort study in the Rhine-Main-Region in
western Mid-Germany. The GHS has been approved by
the local ethics committee and by the local and federal
data safety commissioners. The primary aim of the study
is to evaluate and improve cardiovascular risk stratifica-
tion. The sample was drawn randomly from the local
registry in the city of Mainz and the district of Mainz-
Bingen. The sample was stratified 1:1 for gender and
residence and in equal strata for decades of age. Inclu-
sion criteria were age 35 to 74 years and written in-
formed consent. Persons with insufficient knowledge of
German language, or those who reported that they were
not able to visit the study center on their own (due to their
physical and/or mental condition) were excluded. The re-
sponse rate (defined as the recruitment efficacy propor-
tion, i.e. the number of persons with participation in or
appointment for the baseline examination divided by the
sum of number of persons with participation in or ap-
pointment for the baseline examination plus those with
refusal and those who were not contactable) was 60.3%.
Due to the ongoing recruitment of the GHS, which is
conducted in waves, a final statement concerning the re-
sponse rate cannot be made at this time. According to the
protocol, descriptive analysis of the cross-sectional data
was planned for the first 5000 participants of the study.
The design and the rationale of the Gutenberg Health
Study (GHS) have been described in detail elsewhere [26].
Materials and assessment
The 5-hour baseline-examination in the study center com-
prised evaluation of prevalent classical cardiovascular risk
factors and clinical variables, a computer-assisted personal
interview, laboratory examinations from a venous blood
sample, blood pressure and anthropometric measurements.
Wiltink et al. BMC Psychiatry 2013, 13:223 Page 3 of 7
http://www.biomedcentral.com/1471-244X/13/223In general, all examinations were taken out according to




Depression was measured by the Patient Health Question-
naire (PHQ-9); caseness was defined by a score ≥ 10 with a
sensitivity of 81% and a specificity of 82% for depressive dis-
order [27]. The somatic-affective and cognitive-affective di-
mensions of depression were defined according to prior
studies [28-30]. Four PHQ-9 items related to problems with
sleep, fatigability, appetite, and psychomotor agitation/re-
tardation were classified as somatic-affective symptoms,
whereas 5 items, related to lack of interest, depressed
mood, negative feelings about self, concentration problems
and suicidal ideation, were classified as cognitive-affective
symptoms of depression [31]. While we were aware, that
dimensions of depression (cognitive-affective and somatic-
affective) in the community might differ from those in
cardiovascular settings, we used the same dimensions for
comparison purposes and due to their high face validity
and comparability.
Obesity (anthropometric measures)
Weight, height, waist and hip circumference were mea-
sured according to a written, standardized manual. Waist
circumference (WC) was measured with a tape measure
midway between the lowest rib and the pelvis in position of
expiration, hip circumference was measured at the widest
circumference of the hip. The different anthropometric
measures were calculated: BMI (weight in kg divided by the
square of height in meters); WC (in cm); waist-to-hip ratio
(WHR): WC divided by hip circumference; waist-to-height
ratio (WHtR): WC divided by measured height in cm.
Potential confounders
In addition to age and sex analyses were adjusted for a
wide range of potential confounders (e.g. [32]). We prede-
fined a comprehensive set of confounders with a potential
relation to obesity and/or depression. These confounders
can be grouped into life style factors, classical cardiovascu-
lar risk factors and psychotropic medication.
Life style factors
Physical activity was inquired with the “Short Question-
naire to assess health-enhancing physical activity”
(SQUASH) [33]. The SQUASH captures commuting,
leisure time, household, work and school activities. The
questionnaire does not measure energy expenditure, but
indicates the habitual activity level. Sleeping, lying, sit-
ting and standing were classified as inactivity [34].
The socioeconomic status (SES) was defined according
to Lampert’s and Kroll’s Scores of SES range from 3 to27 while 3 indicates the lowest SES and 27 the highest
SES [35]. Additionally, participants reported, whether
they were living in a partnership. Alcohol use with a
regular daily consumption of 10 g or more for female
participants and 20 g or more for male participants was
defined as heavy [36].
Classical cardiovascular risk factors
Cardiovascular risk factors were defined as follows e.g.
[21,23]: Smoking was dichotomized into non-smokers
(never smoker and ex-smoker) and smokers (occasional
smoker, i.e. <1 cigarette/day, and smoker, i.e. >1 cigarette/
day). Diabetes was defined in individuals with a definite
diagnosis of diabetes by a physician or a blood glucose level
of ≥ 126 mg/dl in the baseline examination after an over-
night fast of at least 8 hours or a blood glucose level of ≥
200 mg/dl after a fasting period < 8 hours. Dyslipidemia
was defined as a definite diagnosis of dyslipidemia by a
physician or an LDL/HDL-ratio of >3.5. Hypertension was
diagnosed, if antihypertensive drugs were taken, or a mean
systolic blood pressure of ≥140 mmHg (diastolic blood
pressure ≥ 90 mmHg) in the 2nd and 3rd standardized
measurement after 8 and 11 minutes of rest. A positive
family history of myocardial infarction (FH-MI) was de-
fined as at least one myocardial infarction in a female first-
degree relative of <65 years or a male first-degree relative
of <60 years.
Psychotropic medication
The following psychotropic medications potentially affecting
mood and/or body weight were chosen as confounders
[37]: non-selective monoamine reuptake inhibitors, select-
ive serotonin reuptake inhibitor, other antidepressants, anti-
psychotics, anxiolytics, hypnotics/sedatives, antiepileptics,
opioids.
Statistical analysis
Statistical analysis was done by SAS for Windows 9.2 TS
Level 1M0 (SAS Institute Inc.) Cary, NC, USA. Data are
presented as numbers/percentage, mean (and 1.96-fold
standard deviation) or median (and 25/75th percentile)
as appropriate.
To analyze the relationship between depression and
obesity, we computed separate linear regression models
with the anthropometric measure (BMI, WC, WHR,
WHtR) as the dependent variable and life style factors,
cardiovascular risk factors and psychotropic medications
as potential confounders of obesity/depression. We ad-
justed for life style factors (SES, partnership, physical ac-
tivity, alcohol use), the traditional cardiovascular risk
factors (smoking status, diabetes, dyslipidemia, hyperten-
sion, family history of myocardial infarction) and psycho-
pharmacological treatments. Depressive symptoms were
evaluated with two separate analyses: a) including the
Table 1 Sample characteristics 1)
Total N = 4907-4970 3)
% (N)
Sex, female 49.1 (2438)
Age, in years; mean (age-range 35–74) 55.5
Partnership, yes 82.4 (4093)
SES, mean (± 1.96 SD) 12.6 (3.9, 21.3)
Depression (PHQ; > = cut-off of 10) 7.2 (354)
Total Score, median (Q1, Q3) 3.0 (1.0, 6.0)
Somatic-affective symptoms, median (Q1, Q3) 2.0 (1.0, 3.0)
Cognitive-affective symptoms, median (Q1, Q3) 1.0 (0, 2.0)
Smoking status, current 19.2 (950)
Physical activity, mean (± 1.96 SD) 2) 7349.2 (−218.3, 14916.7)
Alcohol (heavy use) 28.4 (1407)
Somatic conditions
Obesity (BMI > =30) 24.2 (1204)
BMI, mean (± 1.96 SD) 27.3 (17.9, 36.6)
Waist circumference (cm), mean (± 1.96 SD) 93.9 (67.0, 120.7)
WHtR, mean (± 1.96 SD) 0.55 (0.40, 0.71)




Family history of myocardial infarction 17.8 (883)
Psychotropic medication
Non-selective monoamine reuptake inhibitors 2.3 (113)
Selective serotonin reuptake inhibitor 1.7 (85)






Presented are percent (%) and number (N) resp. mean and ± 1.96 standard
deviation or median (1st, 3rd quartile); 1) Participants with BMI < 18.5 were
excluded (N = 30); 2) N = 986 missing; 3) missings in physical activity not
included in total N.
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Table 1 shows the sociodemographic characteristics (age,
partnership, SES), depressive symptoms, cardiovascular risk
factors (smoking status, physical activity, weight, height,
waist circumference, obesity, hypertension, dyslipidemia,
diabetes, and family history of MI), alcohol use and psycho-
tropic medication. In order to analyze linear relations
between depression and obesity and because of the known
u-shaped association between depression and body weight
[23-25], underweight participants (BMI < 18.5 kg/m2) were
excluded from analyses (N = 30).
The mean age of the participants was 55.5 years (range
35–74 years). 2532 were male (50.9%), and 2438 partici-
pants were female (49.1%). The majority of the partici-
pants reported a low level of education (less than 10th
grade). About 1/3 had completed high school. 24.5% had
a college or university degree. Due to our inclusion cri-
teria (age ≥ 35) pension was common with 33.1%, only
2.2% of the participants were unemployed.
We computed linear regression models with the an-
thropometric measure as a continuous dependent vari-
able. Separately for men and women total depression,
somatic-affective and cognitive-affective symptoms of
depression were used as predictors. The model was add-
itionally adjusted by life style factors, cardiovascular risk
factors and psychotropic medications. Table 2 gives an
overview over the results.
Depression (PHQ-9 total score) was significantly related
to all different measures of obesity, except for WHR in
women. The somatic-affective symptoms of depression
and all anthropometric measures - again except for WHR
in women - were consistently related. These relations were
stronger than those with the total score. The cognitive-
affective symptoms of depression were negatively related
or unrelated to the anthropometric measures. All stan-
dardized regression coefficients (beta) of somatic-affective
depressive symptoms were larger than those for the corre-
sponding cognitive-affective symptoms. Table 2 gives an
overview.
Discussion and conclusions
The aim of our study was to compare BMI as a measure
for general obesity with different anthropometric mea-
sures for abdominal obesity. In our analyses we could
only find small differences between the anthropometricmeasures regarding depression (PHQ-9 total score). We
expected a closer relation between obesity and depression
of the measures taking into account abdominal obesity
compared to BMI, especially for somatic-affective symp-
toms of depression. After full adjustment for potential con-
founders in a general population between 35 to 75 years
associations between the total score (PHQ-9) of depressive
symptoms and different measures of obesity (BMI, WC,
WHtR, WHR) were found in men and women. This finding
corresponds to a recent community based meta-analysis
which has found a positive relationship between obesity
and depression [15]. The sex related difference regarding
Table 2 Linear regression analysis of depression and anthropometric parameters stratified for sex
Female (N = 1850-1853) Male (N = 2073-2075) Total (N = 3922-3928)
Beta B SE p Beta B SE p Beta B SE p
BMI
Depression (PHQ) 0.066 0.0968 0.0345 0.0050 0.043 0.0564 0.0275 0.0400 0.055 0.0762 0.0219 0.0005
Somatic-affective symptoms 0.137 0.3583 0.0715 <.0001 0.094 0.2165 0.0584 0.0002 0.121 0.2980 0.0460 <.0001
Cognitive-affective symptoms −0.067 −0.1786 0.0746 0.0167 −0.046 −0.1076 0.0595 0.0708 −0.061 −0.1538 0.0473 0.0012
WC
Depression 0.064 0.2365 0.0857 0.0058 0.048 0.1777 0.0766 0.0204 0.049 0.1972 0.0571 0.0006
Somatic-affective symptoms 0.122 0.8012 0.1780 <.0001 0.124 0.8184 0.1624 <.0001 0.116 0.8289 0.1201 <.0001
Cognitive-affective symptoms −0.054 −0.3632 0.1861 0.0511 −0.071 −0.4789 0.1655 0.0039 −0.062 −0.4603 0.1237 0.0002
WHtR
Depression 0.064 0.0015 0.0005 0.0043 0.052 0.0011 0.0004 0.0086 0.056 0.0013 0.0003 0.0001
Somatic-affective symptoms 0.126 0.0053 0.0011 <.0001 0.104 0.0040 0.0009 <.0001 0.119 0.0048 0.0007 <.0001
Cognitive-affective symptoms −0.057 −0.0025 0.0012 0.0318 −0.046 −0.0018 0.0009 0.0513 −0.057 −0.0024 0.0007 0.0013
WHR
Depression 0.026 0.0005 0.0005 0.2720 0.069 0.0015 0.0004 0.0008 0.115 0.0009 0.0003 0.0035
Somatic-affective symptoms 0.053 0.0018 0.0010 0.0600 0.107 0.0040 0.0009 <.0001 0.060 0.0029 0.0007 <.0001
Cognitive-affective symptoms −0.025 −0.0019 0.0010 0.3761 −0.029 −0.0011 0.0009 0.2322 −0.023 −0.0017 0.0007 0.0908
Models adjusted for age, socioeconomic status (SES), partnership, smoking status, physical activity, diabetes, dyslipidemia, hypertension, family history of
myocardial infarction, alcohol (heavy use), psychotropic medication (non-selective monoamine reuptake inhibitors, selective serotonin reuptake inhibitor, other
antidepressants, antipsychotics, anxiolytics, hypnotics/sedatives, antiepileptics, opioids), bold type p < .05.
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women) remains unclear. Possibly, different body compo-
sitions as reflected in anthropometric measures might be
related to sex specific affective connotations and depres-
sive symptoms.
Differentiating the depressive symptoms in somatic-
affective and cognitive-affective symptoms, we found that
there was a strong positive association between somatic-
affective symptoms and BMI, WC, WHtR and WHR (only
in men). The relations between cognitive-affective symp-
toms and anthropometric measures however, ranged from
none to slightly negative, and they were all lower than the
relations between the somatic-affective symptoms and the
anthropometric measures. Overall, this finding corre-
sponds to the results of a recent study reporting only
modest relations between cognitive-affective symptoms of
depression and obesity in participants aged between 50
and 70 years [23] in a larger sample of younger obese
starting at the age of 35.
The strong associations between somatic-affective
symptoms of depression and obesity and especially visceral
obesity may indicate an organic etiology of these symp-
toms of depression. It can be assumed that visceral adi-
pose tissue plays a key role in the relationship between
obesity, depression and cardiovascular disease via a higher
production of pro-inflammatory cytokines. Inflammation
is hypothesized to specifically drive somatic, but not
cognitive-affective dimensions of depression, providingone mechanism underlying the relationship of depression
and cardiovascular disease [10].
The main limitation of our study pertains to the cross-
sectional data acquisition. Therefore, causal inferences are
not possible. Selection bias might have occurred regarding
the population with the lower severity of depressive symp-
toms. Therefore, our results might not be generalizable to
persons with major depressive disorders. We found a rela-
tively high rate of missing data for physical activity which
might reflect problems of the SQUASH questionnaire
weakening the results of our regression models. Because
of the relevance of physical activity for body weight, we
decided to leave this variable in the regression analyses.
Results omitting physical activity as predictor (not
reported in this paper) were very similar to those reported.
A further limitation addresses the assessment of visceral fat
only by an indirect anthropometric measure (WC). A com-
puted tomography to identify the amount of visceral adi-
pose tissue would have been desirable e.g. [38]. As the
focus was on different measures of obesity and of depres-
sion, we did not include measures of pro-inflammatory
cytokines into our analyses. As these analyses were explora-
tive with a total of 24 comparisons (fully adjusted models),
there is a risk of finding relations by chance. The strengths
are a) the well characterized, representative sample of par-
ticipants living in the Rhine-Main region in Germany b)
the inclusion of younger participants starting at the age of
35 years and b) the relatively large sample size.
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sion should also a) include measures of visceral obesity, b)
differentiate the somatic and the cognitive symptoms of de-
pression, c) differentiate sex, d) focus on the mechanisms
relating depression and abdominal obesity (e.g. genetics,
pro-inflammatory cytokines) and analyze additional moder-
ators (characteristic of specific disorders, e.g. sarcopenia in
the elderly with diabetes) potentially influencing the rela-
tion between measures of obesity and depressive symptoms
in a longitudinal approach and e) target interventions to
prevent and reduce abdominal obesity, respectively reduce
depression in obese without inducing weight gain (as e.g.
by several antidepressants).
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